Clinical Trial Update: Study of LY300164 for the Treatment of Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study of LY300164 for Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesia
• Parkinson Disease

Drugs mentioned

• LY300164

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Dyskinesias, Parkinson Disease | Phase 2 | Status: COMPLETED